Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)

Sponsor
Janssen Scientific Affairs, LLC (Industry)
Overall Status
Completed
CT.gov ID
NCT01701817
Collaborator
Duke Clinical Research Institute (Other), Bayer (Industry)
13,769
219
52.7
62.9
1.2

Study Details

Study Description

Brief Summary

The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF II) is a multicenter, prospective outpatient disease registry to evaluate the utilization of target-specific antithrombotic agents, such as FXa (factor Xa) inhibitors and direct thrombin inhibitors, and associated outcomes. Importantly, the ORBIT AF II registry will permit the collection and analysis of post-approval observational data needed for evaluating the outcomes associated with these new agents when used in broader patient populations outside of clinical studies. The ORBIT-AF II registry will focus on patients with newly diagnosed atrial fibrillation (AF) as well as those who have been recently started on a target-specific oral anticoagulant agent. Taken together, the ORBIT-AF I and ORBIT-AF II registries will offer a broad and contemporary view of AF therapy.

Condition or Disease Intervention/Treatment Phase
  • Other: Patients with Atrial Fibrillation

Detailed Description

The registry will be used to evaluate, describe, and document the safety of target-specific anticoagulant agents (and other antithrombotic agents) in patients with Atrial Fibrillation (AF), the clinical outcomes associated with their use, the treatment patterns and clinical course of patients with AF, including those who undergo cardiac procedures of interest (ablation, cardioversion, catheterization and surgery, for examples), and characteristics of patients with new onset/first-detected AF. Additionally, the registry will be used to summarize patterns of switching or discontinuation of antithrombotic agents in the United States. The registry will be a nationwide collaboration of health care providers (eg, cardiologists, internists, primary care physicians, electrophysiologists, quality improvement personnel, office/practice managers, research coordinators, and pharmacists). Target enrollment will be approximately 15,000 patients. It is anticipated that enrollment will complete in approximately 3.5 years. Consecutive patients who meet the eligibility criteria will be approached and educated about the registry. Patients who express interest will provide informed consent. Patients enrolled in the registry will be followed for up to 2 years. New patients enrolled in the registry will be followed for up to 1 year. Patient follow-up by their AF care provider will continue as scheduled according to local clinical practice. Data collection will occur at 6 month intervals for approximately 1 year from the time of enrollment of the patient (baseline, 6, and 12 months). Data capture will include demographics, medical history, cardiovascular history, vital signs, echocardiographic and laboratory data, AF status and type (paroxysmal, persistent, long-standing persistent/permanent), pharmacotherapy, contraindications to oral anticoagulant therapy, and provider specialty. Clinical outcomes and safety data capture will include major adverse cardiac events (MACEs).

Study Design

Study Type:
Observational
Actual Enrollment :
13769 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (Orbit-AF II)
Actual Study Start Date :
Feb 20, 2013
Actual Primary Completion Date :
Jul 12, 2017
Actual Study Completion Date :
Jul 12, 2017

Arms and Interventions

Arm Intervention/Treatment
Patients with Atrial Fibrillation (AF)

(1) patients with new onset/first detected Atrial Fibrillation (AF) diagnosed within the 6 months preceding the baseline visit; or (2) patients with AF who had initiation or transition to a FXa (Factor Xa) inhibitor or a direct thrombin inhibitor within the preceding 3 months.

Other: Patients with Atrial Fibrillation
Treatment patterns of AF according to patient demographics, clinical factors, risk stratification, and geographic regions.

Outcome Measures

Primary Outcome Measures

  1. Number of major bleeding events [2 years]

    Major bleeding will be defined according to International Society of Thrombosis and Hemostasis (ISTH) criteria.

Secondary Outcome Measures

  1. Number of major adverse cardiac events [2 years]

    Major cardiac events are defined as stroke or non-central nervous system (non-CNS) systemic embolism, myocardial infarction, and cardiovascular death.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria: - Adult patients with incident (initial diagnosis) AF (Atrial Fibrillation) with electrocardiographic documentation or patients with prevalent (existing diagnosis) AF who had initiation or transition to a FXa (Factor Xa) inhibitor or a direct thrombin inhibitor within the preceding 3 months - anticipated ability to adhere to local regularly scheduled follow-up visits

-

Exclusion Criteria:
  • Atrial flutter only - Anticipated life expectancy less than 6 months - short lasting AF secondary to a reversible condition (e.g. hyperthyroidism, pulmonary embolism, post-cardiothoracic surgery) - Participation in a randomized trial of anticoagulation for AF at the time of enrollment - Was enrolled in the ORBIT-I Registry

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cullman Alabama United States
2 Dothan Alabama United States
3 Fairhope Alabama United States
4 Mobile Alabama United States
5 Tuscaloosa Alabama United States
6 Avondale Arizona United States
7 Glendale Arizona United States
8 Goodyear Arizona United States
9 Scottsdale Arizona United States
10 Sun City Arizona United States
11 Tucson Arizona United States
12 Alhambra California United States
13 Anaheim California United States
14 Bakersfield California United States
15 Banning California United States
16 Beverly Hills California United States
17 Carlsbad California United States
18 Concord California United States
19 East Palo Alto California United States
20 Fresno California United States
21 Huntington Beach California United States
22 Laguna Hills California United States
23 Larkspur California United States
24 Long Beach California United States
25 Los Alamitos California United States
26 Los Angeles California United States
27 Manhattan Beach California United States
28 Mission Hills California United States
29 Newport Beach California United States
30 Northridge California United States
31 Pasadena California United States
32 Pismo Beach California United States
33 Pomona California United States
34 Poway California United States
35 Rancho Mirage California United States
36 San Pedro California United States
37 Santa Rosa California United States
38 Torrance California United States
39 Ventura California United States
40 Aurora Colorado United States
41 Colorado Springs Colorado United States
42 Lakewood Colorado United States
43 Bridgeport Connecticut United States
44 Guilford Connecticut United States
45 Laurel Delaware United States
46 Newark Delaware United States
47 Washington District of Columbia United States
48 Bay Pines Florida United States
49 Clearwater Florida United States
50 Coral Springs Florida United States
51 Eustis Florida United States
52 Jupiter Florida United States
53 Lakeland Florida United States
54 Miami Florida United States
55 Miramar Florida United States
56 Palm Harbor Florida United States
57 Pensacola Florida United States
58 Port Charlotte Florida United States
59 Tampa Florida United States
60 Wellington Florida United States
61 Alpharetta Georgia United States
62 Athens Georgia United States
63 Atlanta Georgia United States
64 Cumming Georgia United States
65 Gainesville Georgia United States
66 Macon Georgia United States
67 Marietta Georgia United States
68 Rome Georgia United States
69 Smyrna Georgia United States
70 Idaho Falls Idaho United States
71 Pocatello Idaho United States
72 Aurora Illinois United States
73 Hines Illinois United States
74 Melrose Park Illinois United States
75 New Lenox Illinois United States
76 North Chicago Illinois United States
77 Peoria Illinois United States
78 Rock Island Illinois United States
79 Anderson Indiana United States
80 Bloomington Indiana United States
81 Hammond Indiana United States
82 Indianapolis Indiana United States
83 La Porte Indiana United States
84 Munster Indiana United States
85 South Bend Indiana United States
86 Davenport Iowa United States
87 Waterloo Iowa United States
88 Overland Park Kansas United States
89 Elizabethtown Kentucky United States
90 Louisville Kentucky United States
91 Mount Sterling Kentucky United States
92 Alexandria Louisiana United States
93 Bossier City Louisiana United States
94 Natchitoches Louisiana United States
95 New Orleans Louisiana United States
96 Shreveport Louisiana United States
97 Rockport Maine United States
98 Annapolis Maryland United States
99 Baltimore Maryland United States
100 Randallstown Maryland United States
101 Salisbury Maryland United States
102 Fall River Massachusetts United States
103 Alpena Michigan United States
104 Bay City Michigan United States
105 Flint Michigan United States
106 Grand Blanc Michigan United States
107 Lansing Michigan United States
108 Lapeer Michigan United States
109 Mount Clemens Michigan United States
110 Rochester Hills Michigan United States
111 Saint Joseph Michigan United States
112 Traverse City Michigan United States
113 Troy Michigan United States
114 Ypsilanti Michigan United States
115 Minneapolis Minnesota United States
116 Bridgeton Missouri United States
117 Kansas City Missouri United States
118 Fremont Nebraska United States
119 Las Vegas Nevada United States
120 Reno Nevada United States
121 Nashua New Hampshire United States
122 Bridgewater New Jersey United States
123 East Brunswick New Jersey United States
124 Flemington New Jersey United States
125 Linden New Jersey United States
126 Manalapan New Jersey United States
127 Moorestown New Jersey United States
128 Mountain Lakes New Jersey United States
129 Somerset New Jersey United States
130 Toms River New Jersey United States
131 Voorhees New Jersey United States
132 Wayne New Jersey United States
133 Albany New York United States
134 Flushing New York United States
135 Huntington New York United States
136 Jackson Heights New York United States
137 Jamaica New York United States
138 Jamestown New York United States
139 Lake Success New York United States
140 Mineola New York United States
141 Mount Kisco New York United States
142 New York New York United States
143 North Massapequa New York United States
144 Utica New York United States
145 Burlington North Carolina United States
146 Chapel Hill North Carolina United States
147 Durham North Carolina United States
148 Elizabeth City North Carolina United States
149 Greensboro North Carolina United States
150 Pinehurst North Carolina United States
151 Sanford North Carolina United States
152 Spartanburg North Carolina United States
153 Canton Ohio United States
154 Cleveland Ohio United States
155 Columbus Ohio United States
156 Mansfield Ohio United States
157 Miamisburg Ohio United States
158 Toledo Ohio United States
159 Worthington Ohio United States
160 Youngstown Ohio United States
161 Tulsa Oklahoma United States
162 Medford Oregon United States
163 Portland Oregon United States
164 Abington Pennsylvania United States
165 Chambersburg Pennsylvania United States
166 Doylestown Pennsylvania United States
167 Ephrata Pennsylvania United States
168 Langhorne Pennsylvania United States
169 Lansdale Pennsylvania United States
170 Philadelphia Pennsylvania United States
171 Sayre Pennsylvania United States
172 West Reading Pennsylvania United States
173 Wynnewood Pennsylvania United States
174 Yardley Pennsylvania United States
175 Providence Rhode Island United States
176 Warwick Rhode Island United States
177 Woonsocket Rhode Island United States
178 Charleston South Carolina United States
179 Easley South Carolina United States
180 Lancaster South Carolina United States
181 Bristol Tennessee United States
182 Jackson Tennessee United States
183 Kingsport Tennessee United States
184 Memphis Tennessee United States
185 Nashville Tennessee United States
186 Oak Ridge Tennessee United States
187 Austin Texas United States
188 Beaumont Texas United States
189 Corpus Christi Texas United States
190 Dallas Texas United States
191 Fort Sam Houston Texas United States
192 Fort Worth Texas United States
193 Houston Texas United States
194 Katy Texas United States
195 McKinney Texas United States
196 Odessa Texas United States
197 Palestine Texas United States
198 Plano Texas United States
199 Round Rock Texas United States
200 San Antonio Texas United States
201 Tomball Texas United States
202 Tyler Texas United States
203 Annandale Virginia United States
204 Lynchburg Virginia United States
205 Mechanicsville Virginia United States
206 Midlothian Virginia United States
207 Newport News Virginia United States
208 Virginia Beach Virginia United States
209 Seattle Washington United States
210 Tacoma Washington United States
211 Vancouver Washington United States
212 Walla Walla Washington United States
213 Charleston West Virginia United States
214 La Crosse Wisconsin United States
215 Milwaukee Wisconsin United States
216 Waukesha Wisconsin United States
217 Wausau Wisconsin United States
218 Rio Grande Puerto Rico
219 Saint Thomas Virgin Islands (U.S.)

Sponsors and Collaborators

  • Janssen Scientific Affairs, LLC
  • Duke Clinical Research Institute
  • Bayer

Investigators

  • Study Director: Janssen Scientific Affairs, LLC Clinical Trial, Janssen Scientific Affairs, LLC

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Janssen Scientific Affairs, LLC
ClinicalTrials.gov Identifier:
NCT01701817
Other Study ID Numbers:
  • CR100871
  • RIVAROXAFL4002
First Posted:
Oct 5, 2012
Last Update Posted:
Jul 21, 2020
Last Verified:
Jul 1, 2020
Keywords provided by Janssen Scientific Affairs, LLC
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 21, 2020